{
  "references": [
    {
      "citation_text": "1. Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, et al. Meningiomas: Knowledge Base, treatment outcomes, and uncertainties. A Rano Review. J Neurosurg. (2015) 122:4-23. doi: 10.3171/2014.7.JNS131644",
      "source_type": "journal",
      "authors": "Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, et al.",
      "title": "Meningiomas: Knowledge Base, treatment outcomes, and uncertainties. A Rano Review",
      "source_name": "J Neurosurg.",
      "publication_year": 2015,
      "volume": "122",
      "issue": null,
      "pages": "4-23",
      "doi_or_url": "10.3171/2014.7.JNS131644",
      "confidence": 100
    },
    {
      "citation_text": "2. Zankl H, Zang KD. Cytological and Cytogenetical Studies on Brain Tumors. 4. Identification of the missing G chromosome in human Meningiomas as no. 22 by fluorescence technique. Humangenetik. (1972) 14:167-9. doi: 10.1007/bf00273305",
      "source_type": "journal",
      "authors": "Zankl H, Zang KD.",
      "title": "Cytological and Cytogenetical Studies on Brain Tumors. 4. Identification of the missing G chromosome in human Meningiomas as no. 22 by fluorescence technique",
      "source_name": "Humangenetik.",
      "publication_year": 1972,
      "volume": "14",
      "issue": null,
      "pages": "167-9",
      "doi_or_url": "10.1007/bf00273305",
      "confidence": 100
    },
    {
      "citation_text": "3. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, et al. Evidence for the complete inactivation of the Nf2 gene in the majority of sporadic Meningiomas. Nat Genet. (1994) 6:180-4. doi: 10.1038/ng0294-180",
      "source_type": "journal",
      "authors": "Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, et al.",
      "title": "Evidence for the complete inactivation of the Nf2 gene in the majority of sporadic Meningiomas",
      "source_name": "Nat Genet.",
      "publication_year": 1994,
      "volume": "6",
      "issue": null,
      "pages": "180-4",
      "doi_or_url": "10.1038/ng0294-180",
      "confidence": 100
    },
    {
      "citation_text": "4. De Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bigozzi U, et al. Screening for mutations in the Neurofibromatosis type 2 (Nf2) gene in sporadic Meningiomas. Hum Genet. (1996) 97:632-7. doi: 10.1007/bf02281874",
      "source_type": "journal",
      "authors": "De Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bigozzi U, et al.",
      "title": "Screening for mutations in the Neurofibromatosis type 2 (Nf2) gene in sporadic Meningiomas",
      "source_name": "Hum Genet.",
      "publication_year": 1996,
      "volume": "97",
      "issue": null,
      "pages": "632-7",
      "doi_or_url": "10.1007/bf02281874",
      "confidence": 100
    },
    {
      "citation_text": "5. Teranishi Y, Okano A, Miyawaki S, Ohara K, Ishigami D, Hongo H, et al. Clinical significance of Nf2 alteration in grade I Meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index. Acta Neuropathol Commun. (2022) 10:76. doi: 10.1186/s40478-022-01377-w",
      "source_type": "journal",
      "authors": "Teranishi Y, Okano A, Miyawaki S, Ohara K, Ishigami D, Hongo H, et al.",
      "title": "Clinical significance of Nf2 alteration in grade I Meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index",
      "source_name": "Acta Neuropathol Commun.",
      "publication_year": 2022,
      "volume": "10",
      "issue": null,
      "pages": "76",
      "doi_or_url": "10.1186/s40478-022-01377-w",
      "confidence": 100
    },
    {
      "citation_text": "6. Abedalthagafi M, Bi WL, Aizer AA, Merrill PH, Brewster R, Agarwalla PK, et al. Oncogenic Pi3k mutations are as common as Akt1 and Smo mutations in meningioma. Neuro Oncol. (2016) 18:649-55. doi: 10.1093/neuonc/nov316",
      "source_type": "journal",
      "authors": "Abedalthagafi M, Bi WL, Aizer AA, Merrill PH, Brewster R, Agarwalla PK, et al.",
      "title": "Oncogenic Pi3k mutations are as common as Akt1 and Smo mutations in meningioma",
      "source_name": "Neuro Oncol.",
      "publication_year": 2016,
      "volume": "18",
      "issue": null,
      "pages": "649-55",
      "doi_or_url": "10.1093/neuonc/nov316",
      "confidence": 100
    },
    {
      "citation_text": "7. Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, et al. Genomic sequencing of Meningiomas identifies oncogenic Smo and Akt1 mutations. Nat Genet. (2013) 45:285-9. doi: 10.1038/ng.2526",
      "source_type": "journal",
      "authors": "Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, et al.",
      "title": "Genomic sequencing of Meningiomas identifies oncogenic Smo and Akt1 mutations",
      "source_name": "Nat Genet.",
      "publication_year": 2013,
      "volume": "45",
      "issue": null,
      "pages": "285-9",
      "doi_or_url": "10.1038/ng.2526",
      "confidence": 100
    },
    {
      "citation_text": "8. Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, et al. Genomic analysis of non-Nf2 Meningiomas reveals mutations in Traf7, Klf4, Akt1, and Smo. Science. (2013) 339:1077-80. doi: 10.1126/science.1233009",
      "source_type": "journal",
      "authors": "Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, et al.",
      "title": "Genomic analysis of non-Nf2 Meningiomas reveals mutations in Traf7, Klf4, Akt1, and Smo",
      "source_name": "Science.",
      "publication_year": 2013,
      "volume": "339",
      "issue": null,
      "pages": "1077-80",
      "doi_or_url": "10.1126/science.1233009",
      "confidence": 100
    },
    {
      "citation_text": "9. Clark VE, Harmanci AS, Bai H, Youngblood MW, Lee TI, Baranoski JF, et al. Recurrent somatic mutations in Polr2a define a distinct subset of Meningiomas. Nat Genet. (2016) 48:1253-9. doi: 10.1038/ng.3651",
      "source_type": "journal",
      "authors": "Clark VE, Harmanci AS, Bai H, Youngblood MW, Lee TI, Baranoski JF, et al.",
      "title": "Recurrent somatic mutations in Polr2a define a distinct subset of Meningiomas",
      "source_name": "Nat Genet.",
      "publication_year": 2016,
      "volume": "48",
      "issue": null,
      "pages": "1253-9",
      "doi_or_url": "10.1038/ng.3651",
      "confidence": 100
    },
    {
      "citation_text": "10. Okano A, Miyawaki S, Hongo H, Dofuku S, Teranishi Y, Mitsui J, et al. Associations of pathological diagnosis and genetic abnormalities in Meningiomas with the embryological origins of the meninges. Sci Rep. (2021) 11:6987. doi: 10.1038/s41598-021-86298-9",
      "source_type": "journal",
      "authors": "Okano A, Miyawaki S, Hongo H, Dofuku S, Teranishi Y, Mitsui J, et al.",
      "title": "Associations of pathological diagnosis and genetic abnormalities in Meningiomas with the embryological origins of the meninges",
      "source_name": "Sci Rep.",
      "publication_year": 2021,
      "volume": "11",
      "issue": null,
      "pages": "6987",
      "doi_or_url": "10.1038/s41598-021-86298-9",
      "confidence": 100
    },
    {
      "citation_text": "11. Patel AJ, Wan YW, Al-Ouran R, Revelli JP, Cardenas MF, Oneissi M, et al. Molecular profiling predicts meningioma recurrence and reveals loss of dream complex repression in aggressive tumors. Proc Natl Acad Sci US A. (2019) 116:21715-26. doi: 10.1073/pnas.1912858116",
      "source_type": "journal",
      "authors": "Patel AJ, Wan YW, Al-Ouran R, Revelli JP, Cardenas MF, Oneissi M, et al.",
      "title": "Molecular profiling predicts meningioma recurrence and reveals loss of dream complex repression in aggressive tumors",
      "source_name": "Proc Natl Acad Sci U S A.",
      "publication_year": 2019,
      "volume": "116",
      "issue": null,
      "pages": "21715-26",
      "doi_or_url": "10.1073/pnas.1912858116",
      "confidence": 100
    },
    {
      "citation_text": "12. Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, et al. DNA methylation-based classification and grading system for meningioma: A multicentre, retrospective analysis. Lancet Oncol. (2017) 18:682-94. doi: 10.1016/s1470-2045(17)30155-9",
      "source_type": "journal",
      "authors": "Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, et al.",
      "title": "DNA methylation-based classification and grading